deltatrials
Unknown PHASE4 NCT02241616

Traditional Chinese Medicine Combined With Entecavir to Treat Refractory Liver Fibrosis in Liver Cirrhosis Due to HBV

A Multi-Center Study to Assess the Efficacy and Safety of Traditional Chinese Medicine Combined With Entecavir for Patients With Refractory Liver Fibrosis in Liver Cirrhosis Due to HBV

Sponsor: Affiliated Hospital of Shandong Univercity of TCM

Updated 12 times since 2017 Last updated: Oct 12, 2018 Started: Sep 30, 2014 Primary completion: Jun 30, 2019 Completion: Jun 30, 2019

A PHASE4 clinical study on Hepatitis B Virus Related Cirrhosis, this trial is ongoing. The trial is conducted by Affiliated Hospital of Shandong Univercity of TCM and has accumulated 12 data snapshots since 2014. Infectious disease trials contribute critical data for public health response and treatment development.

Change History

12 versions recorded
  1. Sep 2025 — Present [monthly]

    Unknown PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Unknown PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE4

    Status: Unknown StatusUnknown

  4. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE4

  5. Nov 2020 — Jan 2021 [monthly]

    Unknown Status PHASE4

    Status: RecruitingUnknown Status

Show 7 earlier versions
  1. Sep 2020 — Nov 2020 [monthly]

    Recruiting PHASE4

  2. Dec 2018 — Sep 2020 [monthly]

    Recruiting PHASE4

  3. Nov 2018 — Dec 2018 [monthly]

    Recruiting PHASE4

  4. Sep 2018 — Nov 2018 [monthly]

    Recruiting PHASE4

    Status: Unknown StatusRecruiting

  5. Jun 2018 — Sep 2018 [monthly]

    Unknown Status PHASE4

  6. Feb 2018 — Jun 2018 [monthly]

    Unknown Status PHASE4

    Status: RecruitingUnknown Status

  7. Jan 2017 — Feb 2018 [monthly]

    Recruiting PHASE4

    First recorded

Sep 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Affiliated Hospital of Shandong Univercity of TCM
  • Beijing Ditan Hospital
  • Beijing YouAn Hospital
  • China-Japan Friendship Hospital
  • Fifth Hospital of Shijiazhuang City
  • Guangxi Ruikang Hospital
  • Huai'an No. 4 People's Hospital
  • Hubei Hospital of Traditional Chinese Medicine
  • Jingmen No.1 People's Hospital
  • Ruijin Hospital
  • Shanghai Zhongshan Hospital
  • Shenzhen Third People's Hospital
  • ShuGuang Hospital
  • The Fifth People's Hospital of Anyang
  • The Fifth People's Hospital of Suzhou
  • The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine
  • The Ninth Hospital of Nanchang
  • The People's Hospital of Ningxia
  • Tongji Hospital
  • Wenzhou Central Hospital
Data source: ShuGuang Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Anyang, China, Beijing, China, Changsha, China, Huai'an, China, Jinan, China, Jingmen, China, Nanchang, China, Nanning, China, Shanghai, China, Shenzhen, China and 5 more location s